Nureca Ltd

Nureca Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nureca Ltd

₹ 235 0.08%
07 Oct - close price
nureca.com BSE: 543264 NSE: NURECA
About

Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.[1]

Key Points

Business Overview:[1][2]
NL is a digitally first, consumer healthcare company with presence in categories such
as home diagnostics, wellness devices, and personal fitness equipment under brands like
Dr Trust and Dr Physio. The company has 277+ Active SKUs, and 7 New Products were launched during Q1FY26

Website BSE NSE
  • Market Cap ₹ 235 Cr.
  • Current Price ₹ 235
  • High / Low ₹ 448 / 198
  • Stock P/E
  • Book Value ₹ 192
  • Dividend Yield 0.00 %
  • ROCE 0.33 %
  • ROE -0.36 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 2.89% over past five years.
  • Company has a low return on equity of -1.93% over last 3 years.
  • Earnings include an other income of Rs.9.32 Cr.
  • Company's cost of borrowing seems high
  • Promoter holding has decreased over last 3 years: -5.67%
  • Working capital days have increased from 237 days to 403 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
26.06 36.79 27.84 21.22 21.23 31.35 22.37 19.56 23.31 32.37 27.21 31.75 34.32
31.56 41.63 29.08 25.03 24.22 30.31 26.80 24.32 26.23 35.03 31.95 31.19 35.40
Operating Profit -5.50 -4.84 -1.24 -3.81 -2.99 1.04 -4.43 -4.76 -2.92 -2.66 -4.74 0.56 -1.08
OPM % -21.11% -13.16% -4.45% -17.95% -14.08% 3.32% -19.80% -24.34% -12.53% -8.22% -17.42% 1.76% -3.15%
1.18 1.91 1.92 2.15 2.69 3.21 5.92 -1.25 5.82 3.21 1.52 2.00 2.59
Interest 0.13 0.10 0.10 0.10 0.11 0.08 0.10 0.17 0.13 0.25 0.14 0.59 0.20
Depreciation 0.59 0.60 0.58 0.54 0.56 0.56 0.56 0.56 0.61 0.57 0.49 0.48 0.48
Profit before tax -5.04 -3.63 0.00 -2.30 -0.97 3.61 0.83 -6.74 2.16 -0.27 -3.85 1.49 0.83
Tax % -23.21% -23.14% -21.74% -22.68% 26.87% 90.36% -34.57% 44.91% 140.74% -14.55% -38.93% 33.73%
-3.87 -2.78 0.03 -1.80 -0.74 2.64 0.08 -4.41 1.20 -0.65 -3.29 2.07 0.55
EPS in Rs -3.87 -2.78 0.03 -1.80 -0.74 2.64 0.08 -4.41 1.20 -0.65 -3.29 2.07 0.55
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 5m Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0 1 1 99 213 256 112 95 115 126
0 1 1 90 152 200 127 106 124 134
Operating Profit 0 0 0 10 62 56 -15 -11 -10 -8
OPM % 0% 3% 4% 10% 29% 22% -14% -12% -8% -6%
0 0 0 0 3 8 7 11 13 9
Interest 0 0 0 1 2 1 0 0 1 1
Depreciation 0 0 0 0 0 1 2 2 2 2
Profit before tax 0 0 0 9 62 61 -11 -3 -0 -2
Tax % 50% 33% 26% 26% 26% -23% -25% 46%
0 0 0 6 47 45 -8 -2 -1 -1
EPS in Rs 0.00 20.00 20.00 6,410.00 46.53 45.31 -8.42 -2.44 -0.67 -1.32
Dividend Payout % 0% 0% 0% 4% 7% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 3%
3 Years: -23%
TTM: 30%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -169%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -36%
1 Year: -27%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: -2%
Last Year: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.01 0.01 0.01 0.01 10 10 10 10 10
Reserves 0 0 0 15 153 194 185 183 182
0 0 0 10 4 4 3 2 4
0 0 1 9 19 11 8 9 10
Total Liabilities 0 0 1 34 186 220 207 204 206
0 0 0 1 3 10 8 6 8
CWIP 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 1 34 62 97 4
0 0 1 33 181 175 136 101 194
Total Assets 0 0 1 34 186 220 207 204 206

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 -8 35 2 12 -3 -19
0 -0 -110 -3 -18 18 9
0 8 92 -7 -2 -1 -1
Net Cash Flow 0 -0 17 -9 -8 14 -11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 365 87 65 47 0 4 14 7 14
Inventory Days 0 101 590 93 135 174 154 156 163
Days Payable 233 849 33 32 13 23 27 26
Cash Conversion Cycle 365 -45 -195 107 103 165 145 136 151
Working Capital Days 182 -12 -45 85 61 109 148 160 403
ROCE % 100% 75% 76% 67% 33% -5% -1% 0%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
70.00% 62.98% 62.98% 62.98% 63.24% 63.24% 63.24% 63.24% 63.78% 64.06% 64.30% 64.33%
1.67% 0.10% 0.10% 0.10% 0.10% 0.07% 0.07% 0.07% 0.69% 0.36% 1.07% 0.07%
0.55% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.04% 0.04%
27.78% 36.92% 36.91% 36.92% 36.67% 36.69% 36.69% 36.69% 35.53% 35.54% 34.59% 35.56%
No. of Shareholders 63,91162,00758,56055,56952,25549,60045,99643,81341,98641,31439,30438,075

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls

  • Jul 2025
    Transcript
    Notes
    PPT
  • May 2025
    Transcript
    Notes
    PPT
  • Jan 2025
    Transcript
    Notes
    PPT
  • Oct 2024
    Transcript
    Notes
    PPT
  • Aug 2024
    Transcript
    Notes
    PPT
  • May 2024
    Transcript
    Notes
    PPT
  • Feb 2024
    Transcript
    Notes
    PPT
  • Nov 2023
    Transcript
    Notes
    PPT
  • Aug 2023
    Transcript
    Notes
    PPT